- Home
- CLDX vs LEU Comparison
CLDX vs LEU Comparison
Compare CLDX & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- LEU
- Stock Information
- Founded
- CLDX N/A
- LEU 1998
- Country
- CLDX United States
- LEU United States
- Employees
- CLDX N/A
- LEU N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- CLDX Health Care
- LEU Industrials
- Exchange
- CLDX Nasdaq
- LEU Nasdaq
- Market Cap
- CLDX 1.3B
- LEU 1.3B
- IPO Year
- CLDX 2008
- LEU 1998
- Fundamental
- Price
- CLDX $16.85
- LEU $64.82
- Analyst Decision
- CLDX Buy
- LEU Strong Buy
- Analyst Count
- CLDX 8
- LEU 5
- Target Price
- CLDX $54.29
- LEU $143.40
- AVG Volume (30 Days)
- CLDX 767.1K
- LEU 545.0K
- Earning Date
- CLDX 05-05-2025
- LEU 05-06-2025
- Dividend Yield
- CLDX N/A
- LEU N/A
- EPS Growth
- CLDX N/A
- LEU N/A
- EPS
- CLDX N/A
- LEU 4.47
- Revenue
- CLDX $7,020,000.00
- LEU $442,000,000.00
- Revenue This Year
- CLDX N/A
- LEU $2.45
- Revenue Next Year
- CLDX $27.01
- LEU $17.65
- P/E Ratio
- CLDX N/A
- LEU $14.50
- Revenue Growth
- CLDX 1.99
- LEU 38.04
- 52 Week Low
- CLDX $16.75
- LEU $33.51
- 52 Week High
- CLDX $47.00
- LEU $122.95
- Technical
- Relative Strength Index (RSI)
- CLDX 29.79
- LEU 34.76
- Support Level
- CLDX $19.48
- LEU $71.88
- Resistance Level
- CLDX $20.38
- LEU $77.70
- Average True Range (ATR)
- CLDX 1.03
- LEU 4.32
- MACD
- CLDX -0.17
- LEU -0.76
- Stochastic Oscillator
- CLDX 2.19
- LEU 21.39
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.